• Something wrong with this record ?

Prevalence and evolution of spasticity in patients suffering from first-ever stroke with carotid origin: a prospective, longitudinal study

T. Dorňák, M. Justanová, R. Konvalinková, M. Říha, J. Mužík, M. Hoskovcová, M. Srp, D. Navrátilová, P. Otruba, O. Gál, I. Svobodová, L. Dušek, M. Bareš, P. Kaňovský, R. Jech,

. 2019 ; 26 (6) : 880-886. [pub] 20190208

Language English Country Great Britain

Document type Journal Article, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc20025832

BACKGROUND AND PURPOSE: The main aim of the study was to document the occurrence and evolution of post-stroke spasticity (PSS). The secondary goal was to identify predictors for increases and decreases in PSS rates during 12 months of subsequent follow-up. METHODS: In a longitudinal, multicenter, prospective cohort study, assessments were done at 7 days (V1), 6 months (V2), and 12 months (V3) after stroke onset. A total of 307 consecutive patients from four comprehensive stroke centers with the first-ever stroke of carotid origin and the presence of motor deficit at day 7 were included. The demographic data, baseline characteristics, Barthel index, degree and pattern of paresis and muscle tone were evaluated and recorded. Spasticity was assessed using the modified Ashworth scale. RESULTS: Spasticity was present in 45.0% of patients at V1, in 49.5% at V2, and in 43.2% at V3. A significant number of patients experienced changes in spasticity between visits: increased/new occurrence of spasticity in 32.5% (V1 and V2) and in 13.6% (V2 and V3) of patients; decreased occurrence/disappearance of spasticity in 18.5% (V1 and V2) and in 18.3% (V2 and V3) of patients. The number of patients with severe spasticity increased throughout the year, from 2.6% to 13.0% (V2) and 12.5% (V3). CONCLUSIONS: Spasticity developed in almost half of the included patients. The degree of spasticity often changed over time, in both directions. The rate of severe spasticity increased during the first year, with the maximum at 6 months following stroke onset.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20025832
003      
CZ-PrNML
005      
20201222154120.0
007      
ta
008      
201125s2019 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1111/ene.13902 $2 doi
035    __
$a (PubMed)30623522
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Dorňák, T $u Faculty of Medicine, Department of Neurology, Palacky University and University Hospital, Olomouc, Czech Republic.
245    10
$a Prevalence and evolution of spasticity in patients suffering from first-ever stroke with carotid origin: a prospective, longitudinal study / $c T. Dorňák, M. Justanová, R. Konvalinková, M. Říha, J. Mužík, M. Hoskovcová, M. Srp, D. Navrátilová, P. Otruba, O. Gál, I. Svobodová, L. Dušek, M. Bareš, P. Kaňovský, R. Jech,
520    9_
$a BACKGROUND AND PURPOSE: The main aim of the study was to document the occurrence and evolution of post-stroke spasticity (PSS). The secondary goal was to identify predictors for increases and decreases in PSS rates during 12 months of subsequent follow-up. METHODS: In a longitudinal, multicenter, prospective cohort study, assessments were done at 7 days (V1), 6 months (V2), and 12 months (V3) after stroke onset. A total of 307 consecutive patients from four comprehensive stroke centers with the first-ever stroke of carotid origin and the presence of motor deficit at day 7 were included. The demographic data, baseline characteristics, Barthel index, degree and pattern of paresis and muscle tone were evaluated and recorded. Spasticity was assessed using the modified Ashworth scale. RESULTS: Spasticity was present in 45.0% of patients at V1, in 49.5% at V2, and in 43.2% at V3. A significant number of patients experienced changes in spasticity between visits: increased/new occurrence of spasticity in 32.5% (V1 and V2) and in 13.6% (V2 and V3) of patients; decreased occurrence/disappearance of spasticity in 18.5% (V1 and V2) and in 18.3% (V2 and V3) of patients. The number of patients with severe spasticity increased throughout the year, from 2.6% to 13.0% (V2) and 12.5% (V3). CONCLUSIONS: Spasticity developed in almost half of the included patients. The degree of spasticity often changed over time, in both directions. The rate of severe spasticity increased during the first year, with the maximum at 6 months following stroke onset.
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a progrese nemoci $7 D018450
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a longitudinální studie $7 D008137
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a svalová spasticita $x epidemiologie $x etiologie $7 D009128
650    _2
$a prevalence $7 D015995
650    _2
$a prospektivní studie $7 D011446
650    _2
$a cévní mozková příhoda $x komplikace $7 D020521
650    _2
$a mladý dospělý $7 D055815
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Justanová, M $u Faculty of Medicine, Department of Neurology, Masaryk University and St. Anne's Teaching Hospital, Brno, Czech Republic.
700    1_
$a Konvalinková, R $u First Faculty of Medicine, Department of Neurology and Center of Clinical Neuroscience, Charles University in Prague, Prague, Czech Republic.
700    1_
$a Říha, M $u Department of Rehabilitation Medicine, Central Military Hospital, Prague, Czech Republic.
700    1_
$a Mužík, J $u Faculty of Medicine, Institute of Biostatistics and Analyses, Masaryk University, Brno, Czech Republic.
700    1_
$a Hoskovcová, M $u First Faculty of Medicine, Department of Neurology and Center of Clinical Neuroscience, Charles University in Prague, Prague, Czech Republic.
700    1_
$a Srp, M $u First Faculty of Medicine, Department of Neurology and Center of Clinical Neuroscience, Charles University in Prague, Prague, Czech Republic.
700    1_
$a Navrátilová, D $u Faculty of Medicine, Department of Neurology, Palacky University and University Hospital, Olomouc, Czech Republic.
700    1_
$a Otruba, P $u Faculty of Medicine, Department of Neurology, Palacky University and University Hospital, Olomouc, Czech Republic.
700    1_
$a Gál, O $u First Faculty of Medicine, Department of Neurology and Center of Clinical Neuroscience, Charles University in Prague, Prague, Czech Republic.
700    1_
$a Svobodová, I $u Faculty of Medicine, Institute of Biostatistics and Analyses, Masaryk University, Brno, Czech Republic.
700    1_
$a Dušek, L $u Faculty of Medicine, Institute of Biostatistics and Analyses, Masaryk University, Brno, Czech Republic.
700    1_
$a Bareš, M $u Faculty of Medicine, Department of Neurology, Masaryk University and St. Anne's Teaching Hospital, Brno, Czech Republic. Department of Neurology, School of Medicine, University of Minnesota, Minneapolis, MN, USA.
700    1_
$a Kaňovský, P $u Faculty of Medicine, Department of Neurology, Palacky University and University Hospital, Olomouc, Czech Republic.
700    1_
$a Jech, R $u First Faculty of Medicine, Department of Neurology and Center of Clinical Neuroscience, Charles University in Prague, Prague, Czech Republic.
773    0_
$w MED00001629 $t European journal of neurology $x 1468-1331 $g Roč. 26, č. 6 (2019), s. 880-886
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30623522 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20201125 $b ABA008
991    __
$a 20201222154115 $b ABA008
999    __
$a ok $b bmc $g 1599977 $s 1116518
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 26 $c 6 $d 880-886 $e 20190208 $i 1468-1331 $m European journal of neurology $n Eur J Neurol $x MED00001629
LZP    __
$a Pubmed-20201125
Back

Find record

Citation metrics

Archiving options